Healthcare -
Biotechnology - NASDAQ - US
$ 4.115
-8.42 %
$ 23.8 M
Market Cap
1.75
P/E
XFOR - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities XFOR - X4 Pharmaceuticals, Inc.
20.3 M
LAST VALUE
-58.39%
2 YEAR CAGR
-32.10%
5 YEAR CAGR
0.00%
10 YEAR CAGR